Wuhan General Group, Inc.: Wuhan General Group Launches Mental Illness Drug Discovery Company Neurai Life Sciences

CAPE TOWN, SA / ACCESSWIRE / January 19, 2022 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health

Related Keywords

Wuhan ,Hubei ,China ,South Africa ,University Of Cape Town ,Western Cape ,Jeff Robinson ,Instagram ,Linkedin ,Bio Sciences Inc ,Twitter ,Nasdaq ,Group Inc ,Institute Of Infectious Diseases ,Youtube ,Neurai Life Sciences ,Securities Exchange ,Facebook ,Wuhan General Group China Aktie ,General Group ,Neurai Life ,Life Sciences ,Chief Executive ,Harvard South Africa Fellow ,Medical Biochemistry ,Infectious Diseases ,Molecular Medicine ,Wuhan General Inc ,Wuhan General ,Chief Executive Officer ,Wuhan General Group ,Over The Counter Bulletin Board ,Looking Statements ,Harbour Statement ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Eneral ,Group ,Aunches ,Ental ,Illness ,Drug ,Discovery ,Company ,Eurai ,Life ,Ciences ,